The global Swine Vaccines Marketstudy analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Type (Swine Influenza, Classical Swine Fever, Porcine Parvovirus, Porcine Circovirus Type 2, M.Hyo, Actinobacillus Pleuropneumonia, PRRS, Foot & Mouth Disease, Pseudorabies, PEDV, Others).
Safeguarding swine health and productivity, the Swine Vaccines Market offers a comprehensive portfolio of vaccines and immunization strategies to prevent and control infectious diseases affecting swine herds. Swine vaccines target a wide range of viral, bacterial, and parasitic pathogens, including porcine reproductive and respiratory syndrome (PRRS), swine influenza virus (SIV), porcine circovirus (PCV), and Mycoplasma hyopneumoniae, protecting against respiratory diseases, reproductive disorders, and enteric infections. This market serves swine producers, veterinarians, and animal health professionals seeking to optimize herd health and performance, offered by veterinary pharmaceutical companies, vaccine manufacturers, and animal health distributors. With the increasing pressure to improve biosecurity, reduce antimicrobial usage, and enhance animal welfare in swine production, the Swine Vaccines Market continues to grow. As stakeholders prioritize disease prevention, vaccination programs, and integrated health management strategies, swine vaccines play a critical role in mitigating disease risks, reducing economic losses, and ensuring sustainable swine production systems globally.
A prominent trend in the Swine Vaccines market is the increasing focus on disease prevention and biosecurity measures within the swine industry. With the rising prevalence of infectious diseases such as porcine reproductive and respiratory syndrome (PRRS), swine influenza, and African swine fever (ASF), swine producers are prioritizing vaccination as a key strategy to control and prevent disease outbreaks. Vaccination programs aim to bolster swine immunity, reduce disease transmission, and minimize economic losses associated with morbidity, mortality, and decreased productivity. Additionally, advancements in vaccine technologies, including novel vaccine formulations, adjuvants, and delivery systems, offer improved efficacy, safety, and convenience, driving adoption and innovation in the Swine Vaccines market. This trend reflects the industry's commitment to proactive disease management and sustainable swine production practices, driving growth and diversification in the Swine Vaccines market.
A key driver propelling the growth of the Swine Vaccines market is the growing global demand for pork products and the increasing emphasis on food safety standards across the swine industry. As the global population expands and urbanizes, there's a corresponding rise in demand for protein-rich diets, including pork, driving growth in the swine industry. Swine producers and food supply chain stakeholders prioritize the implementation of robust biosecurity protocols, vaccination strategies, and quality assurance programs to ensure the safety, health, and welfare of swine populations and the pork products they produce. Furthermore, adherence to food safety standards and regulatory requirements, including vaccination mandates and residue testing, is essential for access to domestic and international markets, driving demand for swine vaccines and related biosecurity solutions. The need to safeguard public health, maintain consumer confidence, and meet regulatory compliance drives investment and innovation in the Swine Vaccines market, positioning vaccines as essential tools for swine health and food safety.
An opportunity in the Swine Vaccines market lies in the expansion into emerging markets and the development of tailored vaccine solutions to address regional disease challenges and production systems. With the increasing importance of the swine industry in emerging economies and regions experiencing population growth and rising incomes, there's a significant opportunity to introduce vaccines tailored to local disease profiles, epidemiological patterns, and swine management practices. Additionally, collaboration with local veterinary authorities, swine producers, and research institutions can facilitate technology transfer, knowledge exchange, and capacity building in emerging markets, enabling the development and implementation of customized vaccination programs. Furthermore, the adoption of novel vaccine technologies such as vectored vaccines, DNA vaccines, and RNA vaccines offers potential for improving vaccine efficacy, duration of immunity, and ease of administration, addressing unmet needs and driving growth and innovation in the Swine Vaccines market. By expanding into emerging markets and developing tailored vaccine solutions, stakeholders can strengthen disease control efforts, enhance swine health, and capitalize on growth opportunities while contributing to global food security and sustainability efforts.
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)
• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Swine Vaccines Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Swine Vaccines Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.
TABLE OF CONTENTS
1 Introduction to 2024 Swine Vaccines Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain
2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations
3 Executive Summary
3.1 Global Swine Vaccines Market Size Outlook, $ Million, 2021 to 2030
3.2 Swine Vaccines Market Outlook by Type, $ Million, 2021 to 2030
3.3 Swine Vaccines Market Outlook by Product, $ Million, 2021 to 2030
3.4 Swine Vaccines Market Outlook by Application, $ Million, 2021 to 2030
3.5 Swine Vaccines Market Outlook by Key Countries, $ Million, 2021 to 2030
4 Market Dynamics
4.1 Key Driving Forces of Swine Vaccines Industry
4.2 Key Market Trends in Swine Vaccines Industry
4.3 Potential Opportunities in Swine Vaccines Industry
4.4 Key Challenges in Swine Vaccines Industry
5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Swine Vaccines Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook
6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts
7 Global Swine Vaccines Market Outlook by Segments
7.1 Swine Vaccines Market Outlook by Segments, $ Million, 2021- 2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
8 North America Swine Vaccines Market Analysis and Outlook To 2030
8.1 Introduction to North America Swine Vaccines Markets in 2024
8.2 North America Swine Vaccines Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Swine Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
9 Europe Swine Vaccines Market Analysis and Outlook To 2030
9.1 Introduction to Europe Swine Vaccines Markets in 2024
9.2 Europe Swine Vaccines Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Swine Vaccines Market Size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
10 Asia Pacific Swine Vaccines Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Swine Vaccines Markets in 2024
10.2 Asia Pacific Swine Vaccines Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Swine Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
11 South America Swine Vaccines Market Analysis and Outlook To 2030
11.1 Introduction to South America Swine Vaccines Markets in 2024
11.2 South America Swine Vaccines Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Swine Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
12 Middle East and Africa Swine Vaccines Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Swine Vaccines Markets in 2024
12.2 Middle East and Africa Swine Vaccines Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Swine Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
BiogénesisBagó
Boehringer Ingelheim GmbH
Ceva
Elanco
HIPRA
Indian Immunologicals Ltd
KM Biologics
Merck & Co. Inc
Phibro Animal Health
Virbac
Zoetis
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Type
Swine Influenza
Classical Swine Fever
Porcine Parvovirus
Porcine Circovirus Type 2
M.Hyo
Actinobacillus Pleuropneumonia
PRRS
Foot & Mouth Disease
Pseudorabies
PEDV
Others
The global Swine Vaccines Market is one of the lucrative growth markets, poised to register a 5.6% growth (CAGR) between 2024 and 2030.
Emerging Markets across Asia Pacific, Europe, and Americas present robust growth prospects.
BiogénesisBagó, Boehringer Ingelheim GmbH, Ceva, Elanco, HIPRA, Indian Immunologicals Ltd, KM Biologics, Merck & Co. Inc, Phibro Animal Health, Virbac, Zoetis
Base Year- 2023; Estimated Year- 2024; Historic Period- 2018-2023; Forecast period- 2024 to 2030; Currency: USD; Volume